Motugivatrep may be well tolerated at 1 year - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Motugivatrep may be well tolerated at 1 year

Patients receiving the treatment alone or alongside existing therapies showed sustained improvements in dry eye symptoms and ocular surface findings in a 52-week phase 3 study.

  • By

  • Andrea Surnit

  • November 10, 2026

  • 4 min

Share

Original Source(s)

Motugivatrep may be well tolerated at 1 year

  • by Andrea Surnit

  • November 10, 2026

Related Content

Topical Cannabinoids and Ocular Pain Relief

Could topical cannabinoids be used to effectively treat ocular pain?

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

Music May Ease Anxiety in Eye Clinics

Background music and multimedia exposure were associated with lower patient-reported anxiety in a quasi-experimental ophthalmology clinic study that used existing clinic audiovisual infrastructure at no additional cost.